Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment

被引:27
作者
Cordani, Marco [1 ]
Strippoli, Raffaele [2 ,3 ]
Somoza, Alvaro [1 ,4 ]
机构
[1] Inst Madrileno Estudios Avanzados Nanociencia IMD, Madrid 28049, Spain
[2] Sapienza Univ Rome, Dept Mol Med, I-00161 Rome, Italy
[3] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, I-00149 Rome, Italy
[4] CSIC, IMDEA, CNB, Nanociencia Associated Unit,Unidad Nanobiotecnol, Madrid 28049, Spain
关键词
nanomaterials; nanomedicine; epithelial-mesenchymal transition; cancer metastasis; cancer therapy; CERIUM OXIDE NANOPARTICLES; WALLED CARBON NANOTUBES; SMALL INTERFERING RNA; NOGO-B RECEPTOR; PANCREATIC-CANCER; GOLD NANOPARTICLES; HEPATOCELLULAR-CARCINOMA; SELENIUM NANOPARTICLES; DRUG-RESISTANCE; BREAST-CANCER;
D O I
10.3390/cancers12010025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial-mesenchymal transition (EMT) has emerged as a key regulator of cell invasion and metastasis in cancers. Besides the acquisition of migratory/invasive abilities, the EMT process is tightly connected with the generation of cancer stem cells (CSCs), thus contributing to chemoresistance. However, although EMT represents a relevant therapeutic target for cancer treatment, its application in the clinic is still limited due to various reasons, including tumor-stage heterogeneity, molecular-cellular target specificity, and appropriate drug delivery. Concerning this last point, different nanomaterials may be used to counteract EMT induction, providing novel therapeutic tools against many different cancers. In this review, (1) we discuss the application of various nanomaterials for EMT-based therapies in cancer, (2) we summarize the therapeutic relevance of some of the proposed EMT targets, and (3) we review the potential benefits and weaknesses of each approach.
引用
收藏
页数:40
相关论文
共 230 条
[1]   Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer [J].
Afkham, Amir ;
Aghebati-Maleki, Leili ;
Siahmansouri, Homayoon ;
Sadreddini, Sanam ;
Ahmadi, Majid ;
Dolati, Sanam ;
Afkham, Nahid Manafi ;
Akbarzadeh, Parvin ;
Jadidi-Niaragh, Farhad ;
Younesi, Vahid ;
Yousefi, Mehdi .
PHARMACOLOGICAL REPORTS, 2018, 70 (03) :418-425
[2]   Nanomedicine: An effective tool in cancer therapy [J].
Aftab, Saima ;
Shah, Afzal ;
Nadhman, Akhtar ;
Kurbanoglu, Sevinc ;
Ozkan, Sibel Aysil ;
Dionysiou, Dionysios D. ;
Shukla, Shyam S. ;
Aminabhavi, Tejraj M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 540 (1-2) :132-149
[3]   Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression [J].
Agarwalla, Pritha ;
Mukherjee, Sudip ;
Sreedhar, Bojja ;
Banerjee, Rajkumar .
NANOMEDICINE, 2016, 11 (19) :2529-2546
[4]  
Akhtar A, 2017, J BIOMED RES, V31, P177, DOI 10.7555/JBR.31.20160059
[5]  
Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev.bioeng-071811-150124, 10.1146/annurev-bioeng-071811-150124]
[6]   EMT: 2016 [J].
Angela Nieto, M. ;
Huang, Ruby Yun-Ju ;
Jackson, Rebecca A. ;
Thiery, Jean Paul .
CELL, 2016, 166 (01) :21-45
[7]  
Argyrou Maria, 2013, Int J Mol Imaging, V2013, P290750, DOI 10.1155/2013/290750
[8]   Gold nanoparticles: opportunities and challenges in nanomedicine [J].
Arvizo, Rochelle ;
Bhattacharya, Resham ;
Mukherjee, Priyabrata .
EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (06) :753-763
[9]   Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle [J].
Arvizo, Rochelle R. ;
Saha, Sounik ;
Wang, Enfeng ;
Robertson, J. David ;
Bhattacharya, Resham ;
Mukherjee, Priyabrata .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (17) :6700-6705
[10]   Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment [J].
Augustine, Christina K. ;
Yoshimoto, Yasunori ;
Gupta, Mukur ;
Zipfel, Patricia A. ;
Selim, M. Angelica ;
Febbo, Phillip ;
Pendergast, Ann Marie ;
Peters, William P. ;
Tyler, Douglas S. .
CANCER RESEARCH, 2008, 68 (10) :3777-3784